Flow Neuroscience receives Series A funding to make self-managed medical device available globally. Five global investors back revolutionary depression treatment
10.08.2021 – Flow Neuroscience, creator of Europe’s only medically approved transcranial direct current stimulation (tDCS) devic..
News









